If you're not comfortable, don't buy it
patients should be advised to seek immediate medical attention for severe, persistent abdominal pain Gallbladder disease : cholelithiasis and cholecystitis have been reported with GLP-1 receptor agonists [11] [22] Diabetic retinopathy complications : particularly in patients with pre-existing retinopathy who experience rapid improvement in glucose control Common adverse effects of Januvia include: Upper respiratory tract infections and nasopharyngitis Headache and gastrointestinal disturbances (though generally milder than with GLP-1 agonists) Rare but serious risks : acute pancreatitis, severe joint pain, hypersensitivity reactions, and bullous pemphigoid (a serious skin condition) When used together, there is a theoretical increased risk of gastrointestinal side effects , particularly nausea, as both medications influence gut hormone pathways

Safety Considerations and When to Discuss Timing with Your Provider Semaglutide injection is safe to administer regardless of meal status from a pharmacokinetic standpoint
Of these, the incretin hormone, glucagon-like peptide 1, is probably the most important
Given these limitations, there is an urgent need for more effective treatments for APAP overdose
Avoid weight/obesity bias in deciding who should discontinue GLP-1RA therapy